Skip to main content
Premium Trial:

Request an Annual Quote

Canada s Virtek Sells Microarray Business to Bio-Rad

NEW YORK, June 28--Bio-Rad bought the microarray division of the Canadian laser and automation company Virtek Vision for more than C$10 million (US $6.6 million), Virtek said today.


Bio-Rad will obtain all property related to Virtek's ChipReader microarray scanner, its ChipWriter Pro spotter, and its arraying and picking systems.


Bio-Rad will establish a new microarray and automation business unit in Virek's operations center in Waterloo, Ontario, and has hired Virtek's employees to continue developing the microarray technology.

More specific financial details of the transaction were not available.


Bio-Rad is a major manufacturer of lab products and clinical diagnostics based in Hercules, Calif.


Virtek develops lasers for a range of industries. The company has been seeking a purchaser for its microarray division for four months, in an effort to return to profitability.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more